What Wyden, Rifkin are charging; Issues in finding appropriate patients

What Wyden, Rifkin are charging

WASHINGTON - A congressional inquiry into human growth hormone marketing practices, sparked by the recent indictment of a Protropin distributor and a Genentech Inc. marketing executive, is being fueled with data from a group led by biotechnology critic Jeremy Rifkin. ...